Last reviewed · How we verify
NCT05764018: HypoCaff
Caffeine and Hypoxia During Exercise in Males and Females
NA trial testing Caffeine in Caffeine in 29 participants. Completed in 19 March 2024.
19 March 2024
Quick facts
| Lead sponsor | Jozef Stefan Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 29 |
| Start date | 6 March 2023 |
| Primary completion | 19 March 2024 |
| Estimated completion | 19 March 2024 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
Conditions studied
Sponsor
Jozef Stefan Institute
Who can join
Adults 18 to 30, any sex, with Caffeine or Hypoxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several high-altitude destinations recommend their visitors to avoid caffeine, theoretically due to the associated diuresis which could contribute to acute mountain sickness. There is however no direct evidence for this association. In fact, caffeine ingestion is known to improve exercise performance at sea level, and may therefore help mountaineers during expeditions. Sport science research is largely conducted in male participants, and the findings from these studies are assumed to apply to the female population. Given the known sex differences in body composition, hormones, and other physiological factors, this may not be appropriate. It is therefore important to conduct research in women, to allow for female-specific recommendations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05764018
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Caffeine
Trials testing the same drug.
- NCT07456670 — Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support · Phase 2 · not yet recruiting
- NCT07520864 — Effects of Caffeine on Elite Weightlifting Performance · NA · completed
- NCT07479875 — Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes · NA · completed
- NCT07466732 — Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males · EARLY_PHASE1 · enrolling by invitation
- NCT07458594 — Combined Caffeine and Rhodiola Rosea on Aerial Duel Performance in Soccer · NA · completed
Other recruiting trials for Caffeine
Currently open trials in the same condition.
- NCT07469852 — Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males · Phase 1, PHASE2 · active not recruiting
- NCT07404254 — Effects of Variations in Caffeinated Beverages on Well-being · NA · recruiting
- NCT06763172 — Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI · Phase 4 · recruiting
- NCT05325502 — Does Caffeine Facilitate Human Reward Learning Behaviors? · NA · active not recruiting
- NCT05454332 — The Caffeine Therapy in the Fetal to Neonatal Transition · Phase 4 · recruiting
Other Jozef Stefan Institute trials
Trials by the same sponsor.
- NCT06097754 — Intermittent Exogenous Ketosis (IEK) at High Altitude · NA · unknown
- NCT04739904 — Hypoxia Intolerance in Preterm Individuals · completed
- NCT04579770 — Effect of Oral Ketone and Sodium Bicarbonate Administration During Endurance Exercise in Hypoxia · NA · completed
- NCT03497871 — Personal Decision Support System for Heart Failure Management · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05764018 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jozef Stefan Institute
- Last refreshed: 12 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05764018.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing